Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Using Open and Closed Abdomen Techniques for Colorectal Peritoneal Metastases and Peritoneal Pseudomyxoma Recurrences: Results from Six French Expert Centers.
Fiche publication
Date publication
novembre 2024
Journal
Annals of surgical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MARCHAL Frédéric
Tous les auteurs :
Tidadini F, Arvieux C, Glehen O, Sourrouille I, Marchal F, Abba J, Malgras B, Quesada JL, Pocard M, Ezanno AC
Lien Pubmed
Résumé
Standard treatment for resectable peritoneal metastases (PM) combines cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC); however, the rate of recurrence remains high and repeat CRS/HIPEC may be considered in well-selected patients. We describe our postoperative and oncological outcomes.
Mots clés
Colorectal peritoneal metastases, Cytoreduction surgery (CRS), Hyperthermic intraperitoneal chemotherapy (HIPEC), Oncological outcomes, Peritoneal pseudomyxoma, Repeat CRS/HIPEC
Référence
Ann Surg Oncol. 2024 11 4;: